Disclosure Of Interests In Other Entities [Text Block]

Xspray Pharma - Filing #679275

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Disclosure of interests in other entities [text block]
Moderbolaget, kSEK 2023-12-31 2022-12-31<
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Namn Kapitalandel*
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
217 815 SEK
132 229 SEK
Non-current assets
547 448 SEK
453 200 SEK
Current liabilities
39 903 SEK
28 851 SEK
Non-current liabilities
31 947 SEK
560,000 SEK
Revenue
SEK
SEK
Profit (loss)
- SEK
- SEK
179 667 SEK
179 667 SEK
- SEK
SEK
SEK
131 670 SEK
131 670 SEK
- SEK
SEK
Comprehensive income
- SEK
- SEK
179 851 SEK
179 667 SEK
- SEK
184,000 SEK
SEK
SEK
131 670 SEK
131 670 SEK
- SEK
SEK
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
- SEK
- SEK
184,000 SEK
- SEK
- SEK
184,000 SEK
SEK
SEK
SEK
SEK
- SEK
SEK
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
166 303 SEK
120 166 SEK
271 881 SEK
Tax expense (income)
17,000 SEK
SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.